Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease

• Main Authors: Yanyong Xu (Author), Yingdong Zhu (Author), Shuwei Hu (Author), Xiaoli Pan (Author), Fathima Cassim Bawa (Author), Helen H. Wang (Author), David Q.-H. Wang (Author), Liya Yin (Author), Yanqiao Zhang (Author)
• Format: Book
• Published: Elsevier, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Hepatic miR-34a expression is elevated in diet-induced or genetically obese mice and patients with non-alcoholic steatohepatitis (NASH), yet hepatocyte miR-34a's role in the progression of non-alcoholic fatty liver disease (NAFLD) from non-alcoholic fatty liver (NAFL) to NASH remains...